Table 2.
Summary patient characteristics by metformin exposure status
| Metformin exposed periods | Metformin unexposed periods | |
|---|---|---|
| (60,738.1 years) | (66,165.9 years) | |
| Age (Years) a | 65.7 (57.3 - 73.5) | 70.2 (61.1 – 78.1) |
| HbA1c % | 7.3 (6.7- 8.3) | 6.7 (6.2- 7.6) |
| (mmol/mol) a | 56 (50 – 67) | 50 (44 - 60) |
| Diabetes Duration (years) a | 6.9 (3.7 – 11.2) | 4.3 (1.8 – 8.9) |
| eGFR category (%) | ||
| >60 | 44,830.6 (73.8) | 39,332.4 (59.4) |
| 30-60 | 12,575.1 (20.7) | 18,775.3 (28.3) |
| <30 ml/min/1.732 | 236.8 (0.4) | 1592.7 (2.4) |
| ACE/ARB use (%) | 25,572.6 (42) | 21,827.7 (33) |
| NSAID use (%) | 5967.4 (10) | 6140.8 (9) |
aMedian & IQR